| __timestamp | BioCryst Pharmaceuticals, Inc. | Lantheus Holdings, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 51796000 | 13673000 |
| Thursday, January 1, 2015 | 72758000 | 14358000 |
| Friday, January 1, 2016 | 61008000 | 12203000 |
| Sunday, January 1, 2017 | 66962000 | 18125000 |
| Monday, January 1, 2018 | 84888000 | 17071000 |
| Tuesday, January 1, 2019 | 107068000 | 20018000 |
| Wednesday, January 1, 2020 | 122964000 | 32788000 |
| Friday, January 1, 2021 | 208808000 | 44966000 |
| Saturday, January 1, 2022 | 253297000 | 311681000 |
| Sunday, January 1, 2023 | 216566000 | 77707000 |
Unlocking the unknown
In the ever-evolving world of biotechnology, research and development (R&D) spending is a key indicator of a company's commitment to innovation. Over the past decade, BioCryst Pharmaceuticals, Inc. and Lantheus Holdings, Inc. have demonstrated contrasting strategies in their R&D investments. From 2014 to 2023, BioCryst's R&D expenses surged by over 300%, peaking in 2022. This reflects their aggressive pursuit of groundbreaking therapies. In contrast, Lantheus Holdings, Inc. showed a more conservative approach, with a notable spike in 2022, where their R&D expenses increased by over 600% compared to 2014. This sudden rise suggests a strategic pivot towards innovation. As the biotech landscape continues to shift, these spending patterns offer a glimpse into the future directions of these industry players.
Research and Development Expenses Breakdown: Zoetis Inc. vs Lantheus Holdings, Inc.
Research and Development Investment: Biogen Inc. vs Lantheus Holdings, Inc.
Analyzing R&D Budgets: Bio-Techne Corporation vs BioCryst Pharmaceuticals, Inc.
Research and Development: Comparing Key Metrics for Jazz Pharmaceuticals plc and BioCryst Pharmaceuticals, Inc.
R&D Spending Showdown: Lantheus Holdings, Inc. vs Madrigal Pharmaceuticals, Inc.
Comparing Innovation Spending: Lantheus Holdings, Inc. and Alpine Immune Sciences, Inc.
Research and Development Investment: Lantheus Holdings, Inc. vs TG Therapeutics, Inc.
Research and Development: Comparing Key Metrics for Opthea Limited and BioCryst Pharmaceuticals, Inc.
Research and Development Investment: Viking Therapeutics, Inc. vs BioCryst Pharmaceuticals, Inc.
R&D Spending Showdown: Amicus Therapeutics, Inc. vs BioCryst Pharmaceuticals, Inc.
Analyzing R&D Budgets: Mesoblast Limited vs BioCryst Pharmaceuticals, Inc.
R&D Insights: How BioCryst Pharmaceuticals, Inc. and Evotec SE Allocate Funds